Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006668 |
YEM_ID: | YEM-19 |
ID: | TCMBANKHE006668/YEM-19 |
植物拉丁名: |
|
功能与主治: | See Aquilaria agallocha./See Aquilaria agallocha . |
药用植物名: | 白木香 |
药名: | 沉香 |
来源: | 云南民族药物志：第一卷 |
药用部位: | resinous wood |
使用民族: | 阿昌族/傣族/德昂族/哈尼族/景颇族/傈僳族/彝族/藏族 |
TCM_ID_id: | 4210 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000036 | sakuranetin | 4',5-Dihydroxy-7-methoxyflavanone; AC1LGHGY; SCHEMBL14410473; ZINC338283; ZB010901; AJ-19902; (2R)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one | C16H14O5 | 286.28 g/mol | COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC=C(C=C3)O)O |
| TCMBANKIN000085 | CUCURBITACIN I | JSI-124; cucurbitacin i | C14H9NO2 | 223.23 | CC1(C2=CCC3C4(CC(C(C4(CC(=O)C3(C2C=C(C1=O)O)C)C)C(C)(C(=O)C=CC(C)(C)O)O)O)C)C |
| TCMBANKIN000086 | cucurbitacin e | NSC521775; acetic acid [(5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; .alpha.-Elaterine; [(5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; LMST01010107; .alpha.-Elaterin; NCI60_000150; 19-Nor-9.beta.,10.alpha.-lanosta-1,5,23-triene-3,11,22-trione, 2,16.alpha.,20,25-tetrahydroxy-9-methyl-, 25-acetate; [(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; ELATERIN, ALPHA; [(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; Cucurbitacine E; 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23E)-; Cucurbitacin E; [(6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; [(6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 18444-66-1; C08797; acetic acid [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester | C32H44O8 | 556.7 g/mol | CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3C=C(C(=O)C4(C)C)O)C)C)C)O)O |
| TCMBANKIN000087 | Cucurbitacin D | cucurbitacin d; elatericin | C30H44O7 | 516.67 | CC1(C2=CCC3C4(CC(C(C4CC(=O)C3(C2CC(C1=O)O)C)C(C)(C(=O)C=CC(C)(C)O)O)O)C)C |
| TCMBANKIN000088 | cryptotanshinone | NCI60_031208; CTS; 4733-35-1; A822990; C19H22O3; ZINC02109876; SMR000387041; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g][1]benzoxole-10,11-dione; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-quinone; (1R)-1,6,6-trimethyl-2,3a,7,8,9,11a-hexahydro-1H-naphtho[1,2-g]benzofuran-10,11-dione; NCGC00163650-01; BB_NC-1574; Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-; MolPort-006-823-903; (1R)-1,6,6-trimethyl-1,2,3a,6,7,8,9,11a-octahydrophenanthro[1,2-b]furan-10,11-dione; MLS001049002; 35825-57-1; DTXSID0044072; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[8,7-g]benzofuran-10,11-dione; (-)-Cryptotanshinone; Phenanthro(1,2-b)furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-; SPECTRUM1505812 | C19H20O3 | 296.36 | CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C |
| TCMBANKIN000625 | pimarol | C20H32O | 288.5 g/mol | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)CO)C)C=C | |
| TCMBANKIN000800 | Aquilarinoside A1 | ||||
| TCMBANKIN000871 | 3,4,5-Trimethyoxyphenyl-1-O-β-D-glucopyranoside | ||||
| TCMBANKIN002185 | methyl dehydroabietate | C21H30O2 | 314.5 g/mol | CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C(=O)OC)C | |
| TCMBANKIN002441 | isorhamnetin 3-O-(6″-O-(Z)-p-coumaroyl)-β-D-glucopyranoside | ||||
| TCMBANKIN002670 | (5R,6S)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyr | (5R,6S)-5-ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxan-2-yl; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]ox | 842.84 | ||
| TCMBANKIN002799 | 18-norisopimara-8 | ||||
| TCMBANKIN002959 | 4-hydroxyphenylethanol-8-O-β-D-apiofuranosyl(1→6)-β-D-glucopyranoside | ||||
| TCMBANKIN003012 | 5,6,7,8-Tetramethoxycoumarin | 56317-15-8; 5,6,7,8-tetramethoxychromen-2-one; 5,6,7,8-tetramethoxy-2-chromenone | C13H14O6 | 266.25 | COC1=C(C(=C(C2=C1C=CC(=O)O2)OC)OC)OC |
| TCMBANKIN003508 | Lethedoside A | C24H26O11 | 490.5 g/mol | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC4C(C(C(C(O4)CO)O)O)O)OC)OC | |
| TCMBANKIN003647 | Erythro-guaiacylglycerol-β-coniferyl ether | ||||
| TCMBANKIN003808 | 2-O-α-L-Rhamnopyranosyl-4,6,4′-trihydroxybenzophenone | ||||
| TCMBANKIN004670 | wikstroemin | 608.6 | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)OC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)O)O | ||
| TCMBANKIN004927 | Thero-fi cusesquilignan A | thero-ficusesquilignan A | |||
| TCMBANKIN005088 | 5,8-Dihydroxy-6,7-dimethoxyflavone | LMPK12111431; 5,8-dihydroxy-6,7-dimethoxyflavone; SCHEMBL8160531; 5,8-dihydroxy-6,7-dimethoxy-2-phenyl-4-chromenone; 5,8-dihydroxy-6,7-dimethoxy-2-phenyl-chromone; AKOS030557619; 5,8-dihydroxy-6,7-dimethoxy-2-phenyl-chromen-4-one; 73202-52-5; 5,8-Dihydroxy-6,7-dimethoxy-2-phenyl-4H-chromen-4-one; 6,7-Dimethoxy-5,8-dihydroxy flavone; DTXSID20223451; CTK5D7548; AK588642; 5,8-dihydroxy-6,7-dimethoxy-2-phenylchromen-4-one; AC1L4ADP | C17H14O6 | 314.29 | COC1=C(C(=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)O)OC |
| TCMBANKIN005603 | Snow bile armour | ||||
| TCMBANKIN005856 | Loose primary alcohol | ||||
| TCMBANKIN006171 | 7α-hydroxy- podocarpen-8(14)-en-13-on-18-oic acid | ||||
| TCMBANKIN006218 | 5,8--dihydroxy(2-phenyl)ethyl ketone | ||||
| TCMBANKIN006354 | 7-Hydroxyl-4′,methyl-5-O-glucosidefl avonoid | ||||
| TCMBANKIN006872 | Linoleic acid butyl ester | ||||
| TCMBANKIN006909 | Syringaresinol-4,4′-di-O-β-D-glucopyranoside | ||||
| TCMBANKIN007043 | 6,7-Dihydroxy-2-Methoxy-1,4-Phenanthrenequinone | ||||
| TCMBANKIN007148 | genkwanin-5-O-β-D-glucopyronoside | C28H32O14 | COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O | ||
| TCMBANKIN007324 | 2α-hydroxyursoic acid | ||||
| TCMBANKIN007524 | ent-16,18-dihydroxy-8(14)-pimaren-15-one | C20H32O3 | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)CO)C)C(=O)CO | ||
| TCMBANKIN007557 | 5-hydroxy-borneol | ||||
| TCMBANKIN007934 | Aquilarisinin | C25H30O14 | 554.5 g/mol | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3=CC(=CC(=C3C(=O)C4=CC=C(C=C4)O)O)O)CO)O)O)O | |
| TCMBANKIN008296 | Herpetin | C30H32O9 | COC1=C(C=CC(=C1)CC2COC(C2CO)C3=CC(=C4C(=C3)C(=C(O4)C5=CC(=C(C=C5)O)OC)CO)OC)O | ||
| TCMBANKIN008764 | 7,4′-Dimethylapigenin-5-O-xylosylgucoside | ||||
| TCMBANKIN009041 | Ethyl oleate | 9-Octadecenoic acid (Z)-, ethyl ester; 9-Octadecenoic acid, (Z)-, ethyl ester; NSC 229428; 9-Octadecenoic acid, ethyl ester, (E)-; EINECS 203-889-5; Ethyl cis-9-octadecenoate; 9-OCTADECENOIC ACID ETHYL ESTER (Z); FEMA No. 2450; EINECS 228-082-5; octadec-9-enoic acid ethyl ester; Oleic acid, ethyl ester; 9-Octadecenoic acid (9Z)-, ethyl ester; Ethyl elaidate; ST5410316; ethyl (E)-octadec-9-enoate; (E)-octadec-9-enoic acid ethyl ester; ethyl oleate; 111-62-6; AI3-00657; 6114-18-7; Ethyl oleate (natural); Ethyl (9E)-9-octadecenoate; Elaidic acid ethyl ester; NSC229428; ethyl octadec-9-enoate; Ethyl 9-octadecenoate, (Z)-; (E)-9-Octadecenoic acid ethyl ester; E8377_SIGMA; 9-Octadecenoic acid, ethyl ester; Oleic acid, ethyl ester (6CI,8CI) | C20H38O2 | 310.51 | CCCCCCCCC=CCCCCCCCC(=O)OCC |
| TCMBANKIN009120 | Irifl ophenone 3,5-C-β-D-glucoside | ||||
| TCMBANKIN009423 | ciwujiatone | C22H26O9 | 434.44 | COC1=CC(=CC(=C1O)OC)C2C(C(CO2)C(=O)C3=CC(=C(C(=C3)OC)O)OC)CO | |
| TCMBANKIN009484 | Aquilarisin | C22H20O13 | 492.4 g/mol | COC1=C(C(=C(C2=C1C(=O)C=C(O2)C3=CC=C(C=C3)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O | |
| TCMBANKIN010190 | cucu-rbitacin D | C30H44O7 | 516.7 g/mol | CC1(C2=CCC3C4(CC(C(C4(CC(=O)C3(C2CC(C1=O)O)C)C)C(C)(C(=O)C=CC(C)(C)O)O)O)C)C | |
| TCMBANKIN010482 | Aquilacallane B | ||||
| TCMBANKIN010503 | genkwainin-5-O-β-D-primeveroside | ||||
| TCMBANKIN010899 | 7-Hydroxyl-5,4′-dimethoxyfl avone | ||||
| TCMBANKIN011051 | Aquilarixanthone | C18H16O11 | 408.3 g/mol | C1C(C(C(C(O1)C2=C(C(=C3C(=C2O)C(=O)C4=CC(=C(C=C4O3)O)O)O)O)O)O)O | |
| TCMBANKIN011317 | α-Sitgmasterol | ||||
| TCMBANKIN011495 | hexanorcucurbitacin I | C24H32O5 | 400.5 g/mol | CC(=O)C1C(CC2(C1(CC(=O)C3(C2CC=C4C3C=C(C(=O)C4(C)C)O)C)C)C)O | |
| TCMBANKIN011549 | bis(2-ethylheptyl-)phythalate | bis(2-ethylheptyl)phythalate | |||
| TCMBANKIN011816 | sinenofuranal | 236.39 | CC1CCC2CC3(C1CCC3C=O)OC2(C)C | ||
| TCMBANKIN012173 | Dhydrotanshinone I | ||||
| TCMBANKIN012772 | 5-methoxylfuradehyde3 | ||||
| TCMBANKIN013062 | 6-methoxy-2-[2-(4'-methoxyphenyl)ethyl] chro-mone | 6-methoxy-2-[2-(4'methoxyphenyl)ethyl] chromone | C19H18O4 | 310.3 g/mol | COC1=CC=C(C=C1)CC(C2=CC3=C(C=C2)OC=CC3=O)OC |
| TCMBANKIN013492 | 2-methoxy-4-[(4-hydroxybenzoyl)phenol] 1-o-β-d-[5-o-(3,4-dimethoxybenzoyl)]-apiofuranos-yl-(1→6)-β-d-glucopyranoside | C35H40O17 | COC1=C(C=C(C=C1)C(=O)OCC2(COC(C2O)OCC3C(C(C(C(O3)OC4=C(C=C(C=C4)COC(=O)C5=CC=C(C=C5)O)OC)O)O)O)O)OC | ||
| TCMBANKIN013698 | Acanthopanax ketone | ||||
| TCMBANKIN014023 | Aquisifl avoside | ||||
| TCMBANKIN014103 | 7,3′-Dimethyl-4′-hydroxyl-5-O-gluco-sidefl avonoid | ||||
| TCMBANKIN014171 | dehydrobufotenine | C12H15N2O+ | 203.26 g/mol | C[N+]1(CCC2=CNC3=C2C1=C(C=C3)O)C | |
| TCMBANKIN014819 | endecaphyllacins B | ||||
| TCMBANKIN015137 | Hydroxygenkwanin | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-chromen-4-one; ACon1_000842; MEGxp0_000798; AIDS-219930; AIDS219930; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4-chromenone; hydroxygenkwanin; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychromen-4-one; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-chromone | C22H22O11 | 462.4 | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O |
| TCMBANKIN015197 | isorhamnetin-3-O-(6''-O-(Z)-p-coumaroyl)-β-D-glucopyranoside | ||||
| TCMBANKIN015297 | Aquilarin A | C57H100O8 | CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)C=CC1=CC(=C(C=C1)O)OC | ||
| TCMBANKIN015520 | 6-hydroxy-3-(4-hydroxyphenyl)-5,7-dimethoxy-chromone | BSPBio_002669; 479-83-4; 6-hydroxy-3-(4-hydroxyphenyl)-5,7-dimethoxy-4-chromenone; KBioGR_002557; Spectrum4_001995; 6-hydroxy-3-(4-hydroxyphenyl)-5,7-dimethoxychromen-4-one; 6-hydroxy-3-(4-hydroxyphenyl)-5,7-dimethoxy-chromen-4-one; Spectrum3_001145; KBio3_002169; NSC74436 | C17H14O6 | 314.29 | COC1=C(C(=C2C(=C1)OC=C(C2=O)C3=CC=C(C=C3)O)OC)O |
| TCMBANKIN015873 | Vuankanin | C27H30O14 | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O | ||
| TCMBANKIN016485 | koaburaside | 41653-73-0; AKOS032962323; C14H20O9; W1982; 3,5-dimethoxy-4-hydroxyphenol-1-O-beta-d-glucopyranoside; Koaburaside; BG01620666; (2S,3R,4S,5S,6R)-2-(4-hydroxy-3,5-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; CHEMBL513117; AC1NSXBI; ZINC33832141; MolPort-035-706-126 | C14H20O9 | 332.3 g/mol | COC1=CC(=CC(=C1O)OC)OC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN016527 | 8-C-β-D-Galactopyranosylisovitexin | ||||
| TCMBANKIN016700 | TRANS-p-coumaric acid ethyl ester | ||||
| TCMBANKIN017238 | 18-norpimara-8 | C19H30O | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)O)C)C=C | ||
| TCMBANKIN017252 | 7,4′-Dimethyl-5-O-glucosidefl avonoid | ||||
| TCMBANKIN017377 | 15-dien-4α-ol | ||||
| TCMBANKIN017630 | Phorbol 13-acetate | C22H30O7 | 406.5 g/mol | CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)OC(=O)C)O | |
| TCMBANKIN017727 | Luteolin-7,3′,4′-trimethyl | C24H26O11 | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)OC4C(C(C(C(O4)CO)O)O)O)OC | ||
| TCMBANKIN017919 | 3,8-dihydroxy-4-methoxy-2-oxo-2h-1-benzo-pyran-5-carboxylicacid | 3,8-dihydroxy-4-methoxy-2-oxo-2h-1-benzopyran-5-carboxylic acid | C11H8O7 | 252.18 g/mol | COC1=C(C(=O)OC2=C(C=CC(=C21)C(=O)O)O)O |
| TCMBANKIN018124 | 5-hydroxyl-6,7,3',4',5'-pentamethoxyflavone | ||||
| TCMBANKIN018462 | dihydrokoumine | C20H24N2O | CN1CC2(C3CC4C5C2(CC1C3CO4)C6=CC=CC=C6N5)C=C | ||
| TCMBANKIN018743 | 6,7_dimethoxy_2_methylisocarbostyril | C12H13NO3 | CN1C=CC2=CC(=C(C=C2C1=O)OC)OC | ||
| TCMBANKIN019489 | 3β-Acetoxyfriedelane | ||||
| TCMBANKIN019932 | Syringaresinol-4′-O-β-D-glucopyranoside | ||||
| TCMBANKIN020109 | 6-methoxy-2-(2-phenylethyl)chromone | 2-Phenethyl-6-methoxychromone; 6-METHOXY-2-PHENETHYLCHROMONE; JOYYVGVYUHRBAE-UHFFFAOYSA-N; CTK2I5800; 6-methoxy-2-phenethylchromen-4-one; 84294-89-3; AC1NSY5V; 6-Methoxy-2-(2-phenylethyl) chromone; AKOS030553415; AK583418; 6-METHOXY-2-(2-PHENYLETHYL)CHROMEN-4-ONE; 6-methoxy-2-(2-phenylethyl)-4-chromenone; 6-Methoxy-2-phenethyl-4H-chromen-4-one; 4H-1-Benzopyran-4-one, 6-methoxy-2-(2-phenylethyl)-; 6-methoxy-2-(2-phenylethyl)chromen-4-one; DTXSID40415755 | C18H16O3 | 280.3 g/mol | COC1=CC2=C(C=C1)OC(=CC2=O)CCC3=CC=CC=C3 |
| TCMBANKIN020228 | 3-oxo-22-hydroxyhopane | ||||
| TCMBANKIN020420 | trans-p- coumaric acid ethyl eater | trans-p-coumaric acid ethyl eater | |||
| TCMBANKIN021421 | Erythro-buddlenol C | C32H38O12 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC(CO)C(C5=CC(=C(C=C5)O)OC)O)OC | ||
| TCMBANKIN021552 | 24-Methylenecholesterol | 24-methylene cholesterol | C31H50O2 | 454.73 | CC(C)C(=C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN021629 | justicidin a | C22H18O7 | 394.4 g/mol | COC1=C(C=C2C(=C1)C(=C3C(=C2OC)COC3=O)C4=CC5=C(C=C4)OCO5)OC | |
| TCMBANKIN021758 | Justidin F | ||||
| TCMBANKIN022118 | dihydrocucurbitacin f | C30H48O7 | 520.7 g/mol | CC1(C(C(CC2C1=CCC3C2(C(=O)CC4(C3(CC(C4C(C)(C(=O)CCC(C)(C)O)O)O)C)C)C)O)O)C | |
| TCMBANKIN022141 | isocucurbitacin d | isocucurbitacin D | C30H44O7 | 516.7 g/mol | CC1(C(C(=O)CC2C1=CCC3C2(C(=O)CC4(C3(CC(C4C(C)(C(=O)C=CC(C)(C)O)O)O)C)C)C)O)C |
| TCMBANKIN023144 | 5,8--dihydroxy-(2-methoxyphenyl)ethyl ketone | ||||
| TCMBANKIN023374 | Threo-buddlenol C | C31H36O11 | COC1=CC(=CC2=C1OC(C2CO)C3=CC(=C(C(=C3)OC)OC(CO)C(C4=CC(=C(C=C4)O)OC)O)OC)C=CCO | ||
| TCMBANKIN023569 | 6-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]chromone | C17H14O4 | 282.29 g/mol | C1=CC(=CC=C1CCC2=CC(=O)C3=C(O2)C=CC(=C3)O)O | |
| TCMBANKIN024332 | Aquilacallane A | ||||
| TCMBANKIN024418 | Threo-guaiacylglycerol-β-coniferyl ether | ||||
| TCMBANKIN024517 | 6-methoxy-2-acetyl-3-methyl-1,4-naphtho-quinone-8-o-β-d-glucopyranoside | C20H22O10 | |||
| TCMBANKIN024603 | 4-Acetyl-3,5-dimethoxy-p-quinol | ||||
| TCMBANKIN024668 | 3,4,5-Trimethoxypenyl-1-O-β-D-apiofuranosyl-(1″→6′)glucopyranoside | ||||
| TCMBANKIN025454 | 7-oxo-5,6-Dihydrostigmasterol | ||||
| TCMBANKIN025512 | 2-O-β-D-glucopyranosyl cucurbitacin I | ||||
| TCMBANKIN025818 | Genkwanin-5-O-β-D-glucopyranoside | ||||
| TCMBANKIN025829 | methyl-7-oxodehydroabietate | C21H28O3 | 328.4 g/mol | CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2=O)(C)C(=O)OC)C | |
| TCMBANKIN025922 | tanshinone ⅡA | tanshinoneⅡA | |||
| TCMBANKIN026766 | Irifl ophenone 3-C-β-D-glucoside | ||||
| TCMBANKIN027244 | 6,7-dimethoxy-2-(2-phenylethyl)chromone | 6,7-dimethoxy-2-(2-phenylethyl)chromen-4-one; 6,7-Dimethoxy-2-(2-phenylethyl) chromone; 6,7-dimethoxy-2-(2-phenylethyl)-4-chromenone | C19H18O4 | 310.3 g/mol | COC1=C(C=C2C(=C1)C(=O)C=C(O2)CCC3=CC=CC=C3)OC |
| TCMBANKIN027704 | 9,10-dimethoxy-pterocarpane-3-o-beta-d-glucoside | 9,10-dimethoxypterocarpane-3-o-beta-d-glucoside; 9,10-dimethoxy-pterocarpane-3-o-β-d-gluco-side; 9, 10-dimethoxypterocarpane-3-o-beta-d-glucoside | C23H28O10 | COC1C=C2C3COC4=C(C3OC2=CC1OC)C=CC(=C4)OC5C(C(C(C(O5)CO)O)O)O | |
| TCMBANKIN028417 | 1-benzyloxy--8--naphthol | ||||
| TCMBANKIN028674 | 4-(1,2,3-Tirhydroxypropyl)-2,6-dimethoxyphenyl-1-O-β-D-glucopyranoside | ||||
| TCMBANKIN028848 | sinenofuranol | C14H24O2 | 224.34 g/mol | CC1(C2CCCC3CCC(C3(C2)O1)CO)C | |
| TCMBANKIN028954 | 6-hydroxy-2-(2-hydroxy-2-phenylethyl)chro-mone | C17H14O4 | 282.29 g/mol | C1=CC=C(C=C1)C(CC2=CC(=O)C3=C(O2)C=CC(=C3)O)O | |
| TCMBANKIN029238 | baimuxiniol | ||||
| TCMBANKIN029809 | 7α-hydroxy-β-sitosterol | 7 alpha hydroxy- beta sitosterol | |||
| TCMBANKIN029927 | isobatatasin i | C17H16O4 | 284.31 g/mol | COC1=CC(=C2C(=C1)C=CC3=CC(=C(C=C32)OC)O)OC | |
| TCMBANKIN030818 | Woody hydrocarbon Lactone | ||||
| TCMBANKIN032497 | Indolyl-3-carboxylic acid | ||||
| TCMBANKIN032896 | 4-[3′-(Hydroxymethyl)oxiran-2′-yl]-2,6-dimethoxyphenol | ||||
| TCMBANKIN033244 | 4-Methyldodecane | 4-methyl-Dodecane | C13H28 | 184.36 | CCCCCCCCC(C)CCC |
| TCMBANKIN033521 | evofolinB | evofolin-B; evofolin B; evofo lin B; evofolin b | C17H18O6 | 318.32 g/mol | COC1=C(C=CC(=C1)C(CO)C(=O)C2=C(C(=CC=C2)O)OC)O |
| TCMBANKIN033554 | 5-(3''-hydroxypropyl)-7-methoxy-2-(3',4'-dimethoxyphenyl)benzofuran | C20H22O5 | 342.4 g/mol | COC1=C(C=C(C=C1)C2=CC3=C(O2)C(=CC(=C3)CCCO)OC)OC | |
| TCMBANKIN033681 | baimuxinfuranic acid | baimuxinfuranicacid | C15H24O3 | CC1(C2CCC3(CCCC(C3(C2)O1)C(=O)O)C)C | |
| TCMBANKIN033689 | 3 , 4 ,5- Three of the phenol | ||||
| TCMBANKIN034859 | Aquilarinoside A | ||||
| TCMBANKIN034911 | 7-β-D-glucoside of 5-O-methylapigenin | ||||
| TCMBANKIN035187 | Lethedioside A | C29H34O15 | 622.6 g/mol | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC4C(C(C(C(O4)COC5C(C(C(CO5)O)O)O)O)O)O)OC)OC | |
| TCMBANKIN035225 | persicogenin | persicogenin | C17H16O6 | 316.31 | COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)OC)O)O |
| TCMBANKIN035237 | 6-Hydroxy-2-[2-(4-hydroxyphenyl)ethyl] | ||||
| TCMBANKIN036319 | 5-hydroxy-6-methoxyflavanone-7-O-α-D-galactopyranoside | 448.46 | |||
| TCMBANKIN036804 | acacetin | Linarigenin; KBio2_000595; AIDS014771; SPECTRUM200499; 480-44-4; Acaceztin; 4'-Methoxy-5,7-dihydroxyflavone; Akatsetin; A827453; KBio1_000878; 5,7-Dioxy-4'-methoxyflavone; Apigenin 4'-dimethyl ether; NSC76061; CHEBI:15335; Prestwick1_000695; Spectrum_000135; 5,7-dihydroxy-2-(4-methoxyphenyl)-4-chromenone; NINDS_000878; 00017_FLUKA; ZINC00005600; Acacetin; AIDS-014771; WLN: T66 BO EVJ CR DO1& GQ IQ; Acacetine; IDI1_000878; Flavone, 5,7-dihydroxy-4'-methoxy- (8CI); 5,7-Dihydroxy-2-(4-methoxyphenyl)-4-benzopyrone; Prestwick0_000695; NSC 76061; Spectrum5_000930; SPBio_002770; CHEBI:57284; KBioSS_000595; Prestwick_49; NCGC00095213-03; BCBcMAP01_000082; NCGC00016458-01; KBio2_003163; BPBio1_000935; Prestwick2_000695; KBio2_005731; ACAETIN; SMP1_000001; Apigenin 4'-methyl ether; DivK1c_000878; 7-hydroxy-2-(4-methoxyphenyl)-4-oxo-1-benzopyran-5-olate; Prestwick3_000695; 5,7-dihydroxy-2-(4-methoxyphenyl)chromone; 5,7-Dihydroxy-4'-methoxyflavone; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-methoxyphenyl)-; 5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one; BRN 0277879; Flavone, 5,7-dihydroxy-4'-methoxy-; 2-(4-methoxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; C01470; CAS-480-44-4; Buddleoflavonol; NCGC00095213-01; Linarisenin; EINECS 207-552-3; 5-18-04-00575 (Beilstein Handbook Reference); NCGC00095213-02; ST066889; BSPBio_000849; Apisenin 4'-methyl ether; acacetin ; 5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate; 4'-Methoxyapigenin; 5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one | C16H12O5 | 284.263 | c1([H])c(OC(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])=C([H])C3=O)c3c(O[H])c([H])c1O[H] |
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN037117 | β-Agarofuran | beta-agarofuran | 220.35 g/mol | ||
| TCMBANKIN037238 | Jinkohol | 2,3,4,5,6,7,8,8abeta-Octahydro-3beta,7,8,8-tetramethyl-1H-3abeta,6beta-methanoazulen-7alpha-ol | C15H26O | 222.366 | C1([H])([H])[C@]2([H])[C@@]3(C([H])([H])[C@@]([H])(C([H])([H])C3([H])[H])[C@@](O[H])(C([H])([H])[H])C2(C([H])([H])[H])C([H])([H])[H])[C@@]([H])(C([H])([H])[H])C1([H])[H] |
| TCMBANKIN037355 | 6-methoxy-2-[2-(3'-methoxyphenyl)ethyl] chormone | C19H18O4 | 310.344 | ||
| TCMBANKIN038032 | formononetin | Oprea1_815287; AIDS027672; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one; Isoflavone, 7-hydroxy-4'-methoxy- (8CI); NCI60_042081; NCGC00095207-03; Oprea1_139748; NCIOpen2_005983; SDCCGMLS-0066428.P001; CHEBI:18088; TNP00176; 485-72-3; Formononetol; Isoflavone, 7-hydroxy-4'-methoxy-; 7-hydroxy-3-(4-methoxyphenyl)chromone; Spectrum2_000560; Formononetin; NSC 93360; EINECS 207-623-9; 47752_FLUKA; KBio2_000853; 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone; Spectrum5_000258; KBio3_001519; NSC93360; KBioSS_000853; Spectrum_000373; SPECTRUM102007; KBio2_005989; Biochanin B; KBioGR_001878; NCGC00017269-01; 7-Hydroxy-3-(4′-methoxyphenyl)-4H-benzopyran-4-one; formononetin ; 7-hydroxy-4'-methoxy-isoflavone; BSPBio_002299; ZINC00113304; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI); SBB016445; Spectrum3_000660; 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; Spectrum4_001429; DivK1c_006319; KBio2_003421; SPBio_000639; NCGC00095207-01; KBio1_001263; AIDS-027672; 7-Hydroxy-4'-methoxyisoflavone; C00858; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-; NCGC00095207-02; SpecPlus_000223 | C16H12O4 | 268.264 | C1([H])=C(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])C(c3c(O1)c([H])c(O[H])c([H])c3[H])=O |
| TCMBANKIN038262 | alpha-Sinensal | 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl-, (E,E,E)-; alpha-sinensal; 2,6,10-TRIMETHYL-2,6,9,11-DODECATETRAENAL; (2E,6E,9E)-2,6,10-trimethyldodeca-2,6,9,11-tetraenal; EINECS 241-854-6; .beta.-Sinensal; C09729; 2,6,10-trimethyldodeca-2,6,9,11-tetraenal; 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl-, (2E,6E,9E)-; α-sinensal; 29994-82-9; 4955-32-2; 17909-77-2; .alpha.-Sinensal; (E,E,E)-2,6,10-Trimethyldodeca-2,6,9,11-tetraen-1-al; 2,6,9,11-Dodecatetraenal, 2,6,10-trimethyl- | C15H22O | 218.33 | CC(=CCC=C(C)C=C)CCC=C(C)C=O |
| TCMBANKIN038360 | 2-(3',5'-Dihydroxy-4'-methoxyphenyl)-3-methoxy-5-hydroxy benzofuran | 302.28 g/mol | |||
| TCMBANKIN039046 | 5,7,3',5'-Tetrahydroxy-6-methylflavanone | 302.28 g/mol | |||
| TCMBANKIN040083 | (5S,6R,7S,8S)-Goniotriol | 250.25 g/mol | |||
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN041318 | 6-Hydroxy-2-methyl-5-(5'-hydroxy-1'(R),5'-dimethylhex-3'-enyl)-phenol | ||||
| TCMBANKIN042475 | Neocucurbitacin B | ||||
| TCMBANKIN042686 | 2-(3-Hydroxy-4-methoxyphenyl)-ethyl-1-O-alpha-L-rhamnosyl-(1-3)-beta-D-(4-feruloy)-glucoside | C31H40O15 | c1(O[H])c([H])c(\C([H])=C([H])\C(O[C@]2([H])[C@@]([H])(C([H])([H])O[H])O[C@@]([H])(OC([H])([H])C([H])([H])c3c([H])c(O[H])c(OC([H])([H])[H])c([H])c3[H])[C@]([H])(O[H])[C@@]2([H])O[C@@]4([H])[C@@]([H])( O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])[H])O4)=O)c([H])c([H])c1OC([H])([H])[H] | ||
| TCMBANKIN042798 | 3β,5α,9α,14β-tetrahydroxy-(22e)-ergosta-7,22-dien-6-one | C28H44O5 | CC(C)C(C)C=CC(C)C1CCC2(C1(CCC3(C2=CC(=O)C4(C3(CCC(C4)O)C)O)O)C)O | ||
| TCMBANKIN042858 | Luteolin | Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone | C15H10O6 | 286.236 | c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN042874 | baimuxinal | CTK3E8697; AC1L360E; 3-(2-hydroxypropan-2-yl)-6-methylspiro[4.5]dec-9-ene-10-carbaldehyde; 86408-21-1; Spiro(4.5)dec-6-ene-6-carboxaldehyde, 2-(1-hydroxy-1-methylethyl)-10-methyl-; 2-(2-HYDROXYPROPAN-2-YL)-10-METHYLSPIRO[4.5]DEC-6-ENE-6-CARBALDEHYDE; Baimuxinal | C15H24O2 | 236.35 | CC1CCC=C(C12CCC(C2)C(C)(C)O)C=O |
| TCMBANKIN043644 | pimaric acid | C21H32O2 | 316 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]2(C([H])([H])[H])C(=C([H])[C@@](C([H])=C([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])C([H])([H])C3([H])[H])[C@]3([H])[C@@](C(O[H])=O)(C([H])([H])[H])C 1([H])[H] | |
| TCMBANKIN044853 | Balanophonin | 356.4 g/mol | |||
| TCMBANKIN045879 | 6,8-Dihydroxy-2-(2-phenylethyl)chromone | 282.29 g/mol | |||
| TCMBANKIN045918 | (5s,6r,7r,8r)-goniotriol | C13H14O5 | 250.25 g/mol | C1=CC=C(C=C1)C(C(C2C(C=CC(=O)O2)O)O)O | |
| TCMBANKIN046190 | agarospirol | AC1L6CVK; ICWHTQRTTHCUHW-UHFFFAOYSA-N; 2-(6,10-Dimethylspiro[4.5]dec-6-en-2-yl)-2-propanol; 23811-08-7; NSC-152472; NSC152472; Agaruspirol; AC1Q76LW; CTK5A9809; 59331-07-6; 2-(6,10-dimethylspiro[4.5]dec-9-en-3-yl)propan-2-ol; Hinesol; 2-(6,10-Dimethylspiro[4.5]dec-6-en-2-yl)-2-propanol #; 2-{6,10-DIMETHYLSPIRO[4.5]DEC-6-EN-2-YL}PROPAN-2-OL | C15H26O | 222.37 | CC1CCC=C(C12CCC(C2)C(C)(C)O)C |
| TCMBANKIN046254 | 8-chloro-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydrochromone | C17H17ClO5 | 336.767 | C1(C([H])([H])C([H])([H])c2c([H])c([H])c([H])c([H])c2[H])=C([H])C(C3=C(O1)[C@]([H])(Cl)[C@@]([H])(O[H])[C@@]([H])(O[H])[C@@]3([H])O[H])=O | |
| TCMBANKIN046651 | benzylacetone | NSC813; ZINC01587606; 1-Phenyl-3-butanone; Benzyl acetone; NCGC00090923-01; benzyl acetone; BRN 1907123; beta-Phenylethyl methyl ketone; B16003_ALDRICH; NSC 813; 4-07-00-00713 (Beilstein Handbook Reference); NSC 44829; Methyl phenethyl ketone; EINECS 219-847-4; Phenethyl methyl ketone; Methyl 2-phenylethyl ketone; 2550-26-7; 2-Butanone, 4-phenyl-; benzylacetone; Methyl phenylethyl ketone; 4-Phenylbutan-2-one; NSC44829; AI3-15123; 4-Phenyl-2-butanone | C10H12O | 148.202 | O=C(C([H])([H])[H])C([H])([H])C([H])([H])c1c([H])c([H])c([H])c([H])c1[H] |
| TCMBANKIN047216 | dihydrokaranone | (?)-Dihydrokaranone; (4aR,5S)-4a,5-dimethyl-3-propan-2-ylidene-5,6,7,8-tetrahydro-4H-naphthalen-2-one; (4aR,5S)-3-isopropylidene-4a,5-dimethyl-5,6,7,8-tetrahydro-4H-naphthalen-2-one; dihydrokaranone; 19598-45-9 | C15H22O | 218.335 | C1(=O)\C(=C(/C([H])([H])[H])\C([H])([H])[H])\C([H])([H])[C@@]2(C([H])([H])[H])C(C([H])([H])C([H])([H])C([H])([H])[C@]2([H])C([H])([H])[H])=C1[H] |
| TCMBANKIN048817 | baimuxinic acid | baimuxinicacid | C15H24O3 | 252.349 | C1([H])([H])C([H])=C(C(O[H])=O)[C@@]2(C([H])([H])C([H])([H])[C@@]([H])(C(O[H])(C([H])([H])[H])C([H])([H])[H])C2([H])[H])[C@]([H])(C([H])([H])[H])C1([H])[H] |
| TCMBANKIN048857 | 6-hydroxy-2-(2-phenylethyl)chromone | 6-hydroxy-2-(2-phenylethyl)-4-chromenone; 6-Hydroxy-2-(2-phenylethyl) chromone; 6-hydroxy-2-(2-phenylethyl)chromen-4-one | C17H14O3 | 266.291 | C1(C([H])([H])C([H])([H])c2c([H])c([H])c([H])c([H])c2[H])=C([H])C(c3c(O1)c([H])c([H])c(O[H])c3[H])=O |
| TCMBANKIN049624 | 5,6-Dimethoxy-N-methylphthalimide | 221.21 g/mol | |||
| TCMBANKIN057900 | Aquilarin B | B | [B] | ||
| TCMBANKIN058101 | mangiferin | Chinoinin; 1,3,6,7-tetrahydroxy-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]xanthone; AIDS-073319; 1,3,6,7-tetrahydroxy-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]xanthen-9-one; (1S)-1,5-anhydro-1-(1,3,6,7-tetrahydroxy-9-oxo-9H-xanthen-2-yl)-D-glucitol; C10077; 1,3,6,7-tetrahydroxyxanthone C2-beta-D-glucoside; 1,3,6,7-tetrahydroxy-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-9-xanthenone; 4773-96-0; BCBcMAP01_000240; AIDS073319; M3547_SIGMA; 2-beta-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one; SMP1_000290; 1,3,6,7-tetrahydroxy-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one; Mangiferin; Mangiferin Mangifera indica bark; CHEBI:6682 | C19H18O11 | 422.34 | C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)C4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN058147 | Hhypolaetin 5-O-β-D-glucuronopyranoside | C21H18O16S | C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)OC4C(C(C(C(O4)C(=O)O)O)OS(=O)(=O)O)O)O)O | ||
| TCMBANKIN058185 | (4-hydroxyphenyl)-(2,4,6-trihydroxyphenyl)methanone | iriflophenone; Irifl ophenone | C13H10O5 | 246.21 g/mol | C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2O)O)O)O |
| TCMBANKIN058200 | buddlenoid A | buddl-enoid A;biondnoid i | C30H26O13 | 594.5 g/mol | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=C(C4=O)O)C5=CC=C(C=C5)O)O)O)O)O)O |
| TCMBANKIN058288 | catechol | 430749_ALDRICH; Catechin (phenol); Pyrokatechin [Czech]; NCGC00015283-01; Catechol-UL-14C; NCI-C55856; CI Oxidation Base 26; CHEBI:18135; benzene-1,2-diol; C15571; 120-80-9; InChI=1/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8; C9510_SIAL; Fouramine PCH; 135011_SIAL; Lopac-C-9510; 2-hydroxyphenol; NSC 1573; NCGC00091262-01; Fourrine 68; o-Diphenol; C.I. Oxidation Base 26; o-Dioxybenzene; C00090; ST5214346; (1,2,3,4,5,6-(1)?C?)BENZENE-1,2-DIOL; AB-131/40235236; Lopac0_000280; ortho-Benzenediol; Catechol (phenol); ortho-Hydroquinone; ZINC00330145; 16474-90-1; pyrocatechol; benzenediol; Brenzcatechin; 12385-08-9; C01785; EINECS 204-427-5; EU-0100280; nchembio801-comp10; o-Dihydroxybenzene; Durafur Developer CFouramine PCH; o-Hydroxyphenol; Phthalhydroquinone; 16474-89-8; Catechol-pyrocatechol; CCRIS 741; ACM19481108; AI3-03995; Pyrocatechinic acid; CI 76500; Durafur developer C; o-Phenylenediol; 1,2-dihydroxybenzene; ortho-Hydroxyphenol; Oxyphenic acid; BRN 0471401; c0097; pyrocatechol-ul-14C; CAQ; 37349-32-9; ortho-Dihydroxybenzene; AIDS-108194; C3561_SIAL; o-Benzenediol; ortho-Dioxybenzene; Katechol [Czech]; Pelagol Grey C; Pyrokatechol [Czech]; AIDS108194; Pyrocatechinic acidPyrocatechol; WLN: QR BQ; Pyrocatechine; 1,2-benzenediol; o-Hydroquinone; CATECHOL; Benzene, o-dihydroxy-; pyrocatechin; ortho-Phenylenediol; HSDB 1436; C9593_SIGMA; NSC1573; C.I. 76500;pyrocatechol;o-hydroquinone;o-phenylenediol;1,2-benzenediol | C6H6O2 | 110.11 g/mol | C1=CC=C(C(=C1)O)O |
| TCMBANKIN058313 | (- )- Rosin | Colophony; Q-100859; Rosin soap (disproportionated) solution; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E)-3-phenylprop-2-enoxy]oxane-3,4,5-triol; NP-016058; SCHEMBL15641934; SCHEMBL15641935; ZINC4096342; KB-295943; BG01588641; 69306-80-5; AK109412; 306P805; Rosin, >=95% (HPLC); (2R,3R,4S,5S,6R)-2-[(E)-cinnamyl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2E)-3-phenylprop-2-en-1-yl beta-D-glucopyranoside; AC1NQXDH; 3-Phenylallyl beta-D-glucopyranoside; AN-35731; beta-D-Glucopyranoside,(2E)-3-phenyl-2-propenyl; ROSIN; 85026-55-7; 3-Phenyl-2-propenyl beta-D-glucopyranoside; ROSIN (CHEMICAL); KHPCPRHQVVSZAH-GUNCLKARSA-N; MolPort-019-937-076; trans-Cinnamyl ?-D-glucopyranoside; AKOS016009311; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(2E)-3-phenylprop-2-en-1-yl]oxy}oxane-3,4,5-triol; beta-D-Glucopyranoside, 3-phenyl-2-propenyl, (E)-; N2694; beta-D-Glucopyranoside, (2E)-3-phenyl-2-propenyl; AJ-47988; rosin | C15H20O6 | 296.31 g/mol | C1=CC=C(C=C1)C=CCOC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN058339 | 3-PhenylpropionicAcid | hydrocinnamic acid; Benzenepropanoic acid; HCI; phenylpropionic acid; InChI=1/C9H10O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,11; Benzenepropionic acid; Dihydrocinnamic acid; 4-09-00-01752 (Beilstein Handbook Reference); 135232_ALDRICH; W288918_ALDRICH; 3-phenylpropionic acid; BETA-PHENYLPROPIONIC ACID; CCRIS 3199; Hydrocinnamic acid (8CI); NSC9272; Benzenepropanoic acid; AI3-00892; FEMA No. 2889; 56670_FLUKA; .beta.-Phenylpropionic acid; Phenylpropanoic acid; AIDS-110926; 501-52-0; 3-Phenylpropanoic acid; beta-Phenylpropioic acid; Benzylacetic acid; Phenylpropionic acid; C05629; BRN 0907515; NSC 9272; ST5308541; Phenylpropanoate; 3-Phenyl-propionic acid; EINECS 207-924-5; AIDS110926 | C9H10O2 | 150.17 g/mol | C1=CC=C(C=C1)CCC(=O)O |
| TCMBANKIN058343 | 5,8-dihydroxy-2-(2-phenylethyl) chromone | 5,8-dihydroxy-2-(2-phenylethyl)chromen-4-one; 69809-24-1; 5,8-Dihydroxy-2-(2-phenylethyl) chromone; AIDS132482; 5,8-Dihydroxy-2-(2-phenylethyl)chromone; 4H-1-Benzopyran-4-one, 5,8-dihydroxy-2-(2-phenylethyl)-; 5,8-dihydroxy-2-(2-phenylethyl)-4-chromenone; 5,8-Dihydroxy-2-(2-phenylethyl)-4H-chromen-4-one; NSC626537; AIDS-132482;DPEC | C17H14O4 | 282.29 g/mol | C1=CC=C(C=C1)CCC2=CC(=O)C3=C(C=CC(=C3O2)O)O |
| TCMBANKIN058346 | 2-(2-phenylethyl) chromone | 2-(2-phenylethyl)chromone;Flindersiachromone;2-(2-phenylethyl)-4-chromenone; 2-(2-phenylethyl)chromen-4-one; C09007; Chromone, 2-(2-phenylethyl); 4H-1-Benzopyran-4-one, 2-(2-phenylethyl)-; | C17H14O2 | 250.29 g/mol | C1=CC=C(C=C1)CCC2=CC(=O)C3=CC=CC=C3O2 |
| TCMBANKIN058436 | 2, 4-dihydroxy pyrimidine | NSC3970; C00106; 16908-84-2; U3879_SIGMA; 2,4-Pyrimidinediol; 2-hydroxy-4(3H)-pyrimidinone; 66-22-8; Pirod; 144104-68-7; SQ 7726; Uracil-2-14C; 2,4-Pyrimidinedione; 4433-21-0; D00027; 24897-50-5; U0750_SIGMA; AI3-25470; 766-19-8; U1128_SIGMA; SQ 8493; ST5165192; SQ 6201; 2-hydroxy-4(1H)-pyrimidinone; 2,4-Dioxopyrimidine; 1H-pyrimidine-2,4-dione; Urazil; Pyrod; EINECS 200-621-9; Hybar X; Uracil (JAN/USAN); CHEBI:17568; 6-(3,5-Dimethylbenzyl)-5-ethyl-1-[4-(13-ethyl-17-hydroxy-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylethynyl)benzyloxymethyl]uracil; Uracil-5-d; NCIMech_000782; AC-907/30002021; 2,4-Dihydroxypyrimidine; 42910-77-0; NSC 3970; NSC29742; ZINC00895045; STK301734; AIDS009895; Uracil (8CI); URACIL; Uracil [USAN]; 6-[(3,5-dimethylphenyl)methyl]-5-ethyl-1-[[4-[2-(13-ethyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)ethynyl]phenyl]methoxymethyl]pyrimidine-2,4-dione; pyrimidine-2,4(1H,3H)-dione; 4433-24-3; 2,4-(1H,3H)-pyrimidinedione (9CI); CCRIS 3077; RU 12709; Ura; 2,4(1H,3H)-Pyrimidinedione; BMS 205603-01; InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8; 2,4(1H,3H)-Pyrimidinedione (9CI); NCI60_003718; 4-hydroxy-2(1H)-pyrimidinone; 2,4(1H,3H)-Pyrimidinedione, labeled with tritium; AIDS-009895 | C4H4N2O2 | 112.09 g/mol | C1=CNC(=O)NC1=O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058457 | 6-oxo purine | hypoxanthine;HX;9H-Purin-6-ol disodium salt; 6(1H)-Purinone disodium salt; Purin-6(3H)-one disodium salt; 6-Hydroxypurine disodium salt; 1,7-Dihydro-6H-purin-6-one disodium salt; Hypoxanthine disodium salt;AIDS045522; Spectrum3_001352; NCGC00095622-01; C00262; Spectrum5_000564; Imidazo[5,4-d]pyrimidine, 6-hydroxy-; ST5298920; Sarcine; InChI=1/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10; CHEBI:17368; Hypoxanthine-8-14C; KBio2_001897; PDSP1_000299; 39464-17-0; 3,7-dihydropurin-6-one; Hypoxanthine enol; 6-Oxopurine; Purin-6-ol; Purin-6(3H)-one; DivK1c_006557; HPA; Hypoxanthine (VAN) (8CI); 9H-Purin-6-ol; 68-94-0; 3H-Purin-6-ol; SDCCGMLS-0065594.P002; KBioSS_001897; SPECTRUM310023; Sarkine; KBio3_002383; Purine-6-ol; ST5298925; 25991-07-5; Spectrum_001417; 9H-Purin-6-ol (VAN); SBB004203; Purin-6(1H)-one; BSPBio_003163; KBio1_001501; SpecPlus_000461; KBio2_004465; ZINC05177813; 25991-09-7; Spectrum2_001907; 480-99-9; AI3-52242; H9636_SIGMA; 9H-Purin-6(1H)-one; AIDS-045522; KBio2_007033; 39464-15-8; 6-Hydroxy-1H-purine; 1,9-Dihydro-purin-6-one; 6(1H)-Purinone; Sarkin; ZINC00155652; 184856-40-4; NSC14665; SDCCGMLS-0065594.P001; TULIP028890; Spectrum4_001742; AG-670/31547063; H9377_SIGMA; PDSP2_000297; 1,7-Dihydro-6H-purin-6-one; 6535-89-3; Purine analog; HYPOXANTHINE; 6-Hydroxypurine; 25991-08-6; EINECS 200-697-3; KBioGR_002184; NSC 14665; H0394_SIGMA; 6H-Purin-6-one, 1,7-dihydro-; SPBio_001874 | C5H4N4O | 136.11 g/mol | C1=NC2=C(N1)C(=O)NC=N2 |
| TCMBANKIN058961 | p-methoxybenzylacetone | SR-01000944748-1; 65161_FLUKA; OR13500; CHEMBL3184371; 4-(4-Methoxyphenyl)-2-butanone, >=98%, FCC, FG; AN-24670; p-Methoxybenzylacetone; W-108822; FT-0616645; 4-(4-Methoxyphenyl)-2-butanone; CAS-104-20-1; SBB002546; NSC405366; Tox21_113654; Rasberry ketone methyl ether; AKOS000120662; Anisylacetone; 4-(4-Methoxyphenyl)-2-butanone, analytical standard; 1-(p-Methoxyphenyl)-3-butanone; Methyl oxanone; Methoxybenzylacetone, p-; ZINC1235108; 4-(p-Methoxyphenyl)-2-butanone (natural); Jsp000420; AC1L1UCC; AI3-20279; BRN 1869592; 4-Methoxybenzylacetone; GVG47S4S5V; FEMA No. 2672; LS-2896; NCGC00255063-01; ZX-AT014618; 2-Butanone, 4-(p-methoxyphenyl)- (6CI,7CI,8CI); PCBSXBYCASFXTM-UHFFFAOYSA-N; p-Methoxyphenylbutanone; RT-002825; 4-(4-Methoxyphenyl)-2-butanone, 98%; M19600_ALDRICH; AK163318; 2-BUTANONE, 4-(4-METHOXYPHENYL)-; CC-16593; BB_NC-2171; ACMC-2098b8; VF10076; DB-003441; 2-Butanone, 4-(p-methoxyphenyl)-; KB-34461; 4-(4-methoxy-phenyl)-butan-2-one; M0756; C-24497; EINECS 203-184-2; NSC 405366; FEMA 2672; ZINC01235108; Anisylacetone, p-; I01-5625; 1-(4-Methoxyphenyl)-3-butanone; DSSTox_GSID_47166; 4-(4-Methoxyphenyl)butan-2-one; DSSTox_CID_27166; NCGC00248312-02; ST092728; ANW-15042; ZB016111; KSC496A2J; DTXSID5047166; MFCD00008791; BBV-46872299; Tox21_301165; SCHEMBL1334; DSSTox_RID_82167; BBL027730; 1-(p-Methoxyphenyl)-3-butanone-; AC1Q4CHA; STL146341; ENT 20,279; CTK3J6024; MCULE-5951016256; ANISYL ACETONE; CJ-04791; 4-(4-methoxyphenyl)-butan-2-one; Raspberry ketone methyl ether; L571; Anisyl acetone; MolPort-001-758-492; BG00601893; SR-01000944748; NSC-405366; 104-20-1; ZERO/005545; KS-00000UOD; AX8017381; 4-(p-Methoxyphenyl)-2-butanone; UNII-GVG47S4S5V; W267201_ALDRICH; BB_NC-02171; NCGC00248312-01; ST24042959 | C11H14O2 | 178.23 g/mol | CC(=O)CCC1=CC=C(C=C1)OC |
| TCMBANKIN058971 | cucurbitacin b | Cucurbitacin; Cucurbitacine (B); acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; LMST01010104; NSC144154; 19-nor-9.beta.,10.alpha.-Lanosta-5,23-diene-3,11,22-trione, 9-methyl-2.beta.,16.alpha.,20,25-tetrahydroxy-, 25-acetate; C08794; NSC49451; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; acetic acid [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; Datisca principle B; [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxohex-2-enyl] ester; acetic acid [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-3,11-diketo-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-4-keto-1,1-dimethyl-hex-2-enyl] ester; [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-; [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate; Cucurbitacin B; Datiscn Principle B; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxo-hept-3-en-2-yl] ethanoate; 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, [2.beta.,.gamma.,.beta.,10.alpha.,16.alpha.]-; NCI60_004184; 6199-67-3 | C32H46O8 | 558.7 | CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)C)C)C)O)O |
| TCMBANKIN058974 | 22,23-dihydrocucurbitacin E | dihydrocucurbitacin e | C32H46O8 | 558.7 g/mol | CC(=O)OC(C)(C)CCC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3C=C(C(=O)C4(C)C)O)C)C)C)O)O |
| TCMBANKIN059268 | guineensine | 55038-30-7; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-isobutyltrideca-2,4,12-trienamide; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)trideca-2,4,12-trienamide; (2E,4E,12E)-13-(1,3-benzodioxol-5-yl)-N-isobutyl-trideca-2,4,12-trienamide | C24H33NO3 | 383.5 g/mol | CC(C)CNC(=O)C=CC=CCCCCCCC=CC1=CC2=C(C=C1)OCO2 |
| TCMBANKIN059444 | 5'-methoxy dehydrodiisoeugenol | C21H24O5 | 356.4 g/mol | CC=CC1=CC2=C(C(=C1)OC)OC(C2C)C3=CC(=C(C(=C3)OC)O)OC | |
| TCMBANKIN059456 | cucurbitacin p | C30H48O7 | 520.7 g/mol | CC1(C(C(CC2C1=CCC3C2(C(=O)CC4(C3(CC(C4C(C)(C(=O)CCC(C)(C)O)O)O)C)C)C)O)O)C | |
| TCMBANKIN059549 | dehydrobaimuxinol | C15H24O2 | 236.35 g/mol | CC1(C2CCC3(CCC=C(C3(C2)O1)CO)C)C | |
| TCMBANKIN059551 | 2H-3,9a-Methano-1-benzoxepin-9-methanol, octahydro-2,2,5a-trimethyl-, (3R-(3alpha,5aalpha,9alpha,9aalpha))- | C15H26O2 | 238.37 | CC1(C2CCC3(CCCC(C3(C2)O1)CO)C)C | |
| TCMBANKIN059815 | tanshinone i | C18H12O3 | 276.3 g/mol | CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C4=C3OC=C4C | |
| TCMBANKIN060018 | Costunolide | C15H20O2 | 232.32 g/mol | CC1=CCCC(=CC2C(CC1)C(=C)C(=O)O2)C | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060470 | jinkoheremol;kusunol | C15H26O | 222.37 g/mol | CC1CCC=C2C1(CC(CC2)C(C)(C)O)C | |
| TCMBANKIN060616 | dihydrotanshinoneⅠ | C18H14O3 | 45.043279 | CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CC=C4C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060686 | 7-oxo-β-sitosterol | C29H48O2 | 428.7 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2C(=O)C=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060705 | methyl linoleate | C19H34O2 | 294.47 | CCC=CCC=CCC=CCCCCCCCC(=O)OC | |
| TCMBANKIN060706 | Linolenic acid ethyl ester | C20H34O2 | 306.48 | CCC=CCC=CCC=CCCCCCCCC(=O)OCC | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061063 | methyl hexadecanoate | C17H34O2 | 270.5 g/mol | CCCCCCCCCCCCCCCC(=O)OC | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061134 | Hexacosanoic acid | C26H52O2 | 396.7 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061141 | n-hentriacontane | C31H64 | 436.8 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061142 | n-Dotriacontane | C32H66 | 450.9 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061330 | Luteanin | Artabotrin; Spectrum5_000378; BSPBio_000474; AIDS-138466; KBio2_004255; SPBio_000352; Prestwick1_000597; 545368_ALDRICH; KBio2_006823; Spectrum_001207; 6aalpha-Aporphin-11-ol, 1,2,10-trimethoxy- (8CI); KBio1_001557; BSPBio_002533; 1,2,10-Trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol; 4H-Dibenzo(de,g)quinolin-11-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)- (9CI); KBio3_001753; Prestwick3_000597; KBio2_001687; d-Isocorydine; NSC645316; SBB005942; Prestwick2_000597; 5-21-06-00132 (Beilstein Handbook Reference); NCGC00016453-02; S-(+)-Isocorydine; Luteanine (VAN); KBioSS_001687; 6a-alpha-APORPHIN-11-OL, 1,2,10-TRIMETHOXY-; Isocorydine; Spectrum2_000566; ()-Isocorydine; SpecPlus_000517; SDCCGMLS-0066694.P001; BPBio1_000522; AIDS138466; CAS-475-67-2; Luteanine; BRN 0094792; Prestwick_281; Isocorydine (+); NSC 645316; KBioGR_001998; Prestwick0_000597; C09549; Artabotrine; TNP00260; L-(+)-Isocorydine; NSC 32979; Lindcarpine, N,O-dimethyl-; SPECTRUM1500860; DivK1c_006613; Aporphin-11-ol, 1,2,10-trimethoxy-; 4H-Dibenzo(de,g)quinolin-11-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)-; SPBio_002693; Spectrum4_001699; NCGC00016453-01; Spectrum3_000717; 475-67-2; Uzokoridin; NCGC00142508-01;isocorydine;AC1OCG6Z; (-)-tramadol(1+); FT-0675348; ZB000501; [(1S,2S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]methyl-dimethylazanium; (S,S)-tramadol(1+); {[(1S,2S)-2-HYDROXY-2-(3-METHOXYPHENYL)CYCLOHEXYL]METHYL}DIMETHYLAZANIUM; [(1S,2S)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]-N,N-dimethylmethanaminium; CHEBI:75738 | C20H23NO4 | 341.4 g/mol | CN1CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)OC)OC |
| TCMBANKIN061403 | Abiol | AIDS209944; Methyl Parasept; H3647_SIGMA; Methyl p-hydroxybenzoate; BRN 0509801; FEMA Number 2710; p-Methoxycarbonylphenol; 4-HYDROXY-BENZOIC ACID METHYL ESTER; Benzoic acid, p-hydroxy-, methyl ester; Nipagin M; 4-Hydroxybenzoic acid, methyl ester; Nipagin; p-Oxybenzoesauremethylester [German]; D01400; Methyl chemosept; p-Hydroxybenzoic methyl ester; 4-(Methoxycarbonyl)phenol; Tegosept M; 4-10-00-00360 (Beilstein Handbook Reference); Aseptoform; H6654_SIAL; Methyl 4-hydroxybenzoate; Maseptol; BENZOIC ACID,4-HYDROXY,METHYL ESTER; AI3-01336; NCGC00159376-02; Methylparaben (TN); Metaben; Methyl-p-hydroxybenzoate; 99-76-3; Preserval M; Methylparaben (NF); Methyl parahydroxybenzoate (JP15); ST5214511; p-Hydroxybenzoic acid methyl ester; CCRIS 3946; Methyl ester of p-hydroxybenzoic acid; Methylparaben; p-Hydroxybenzoic acid, methyl ester; Caswell No. 573PP; FEMA No. 2710; NCGC00159376-03; p-Carbomethoxyphenol; Methylben; 47889_SUPELCO; NSC3827; ZINC00001712; AIDS-209944; Preserval; HSDB 1184; Metoxyde; Methaben; Moldex; WLN: QR DVO1; 4-Hydroxybenzoic acid methyl ester; InChI=1/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H; Solbrol M; Methylparaben [USAN]; 54752_FLUKA; Benzoic acid, 4-hydroxy-, methyl ester; Methyl parahydroxybenzoate; component of Heb-Cort MC; 54750_FLUKA; NSC406127; Methyl Butex; Solbrol; Methyl paraben; Paridol; EINECS 202-785-7; M8911_SIAL; Methyl p-oxybenzoate; NSC 3827; W271004_ALDRICH; EPA Pesticide Chemical Code 061201; Methyl parahydroxybenzoate (TN); Methylester kyseliny p-hydroxybenzoove [Czech]; Septos; methyl p-hydroxybenzoate; 4-hydroxybenzoic acid methyl ester; methyl-4-hydroxybenzoate; Methyl paraben; methylparaben | C8H8O3 | 152.15 g/mol | COC(=O)C1=CC=C(C=C1)O |
| TCMBANKIN061561 | vanillic acid | CJ-02984; CHEBI:16632; Vanillate; CHEBI:30816; H36001_ALDRICH; InChI=1/C8H8O4/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,9H,1H3,(H,10,11; BRN 2208364; WKOLLVMJNQIZCI-UHFFFAOYSA-M; 94770_FLUKA; WLN: QVR DQ CO1; MLS000574833; Acide vanillique; vanillicacid; C06672; m-Anisic acid, 4-hydroxy-; VA (VAN); vanil-lic acid; 4-Hydroxy-3-methoxybenzoic acidion; 4-Hydroxy-3-methoxybenzoic acid; Protocatechuic acid, 3-methyl ester; NSC3987; NSC 674322; DB02130; VANILLIC ACID; p-Vanillic acid; NSC 3987; ZB010900; 4-Hydroxy-3-methoxybenzoate; AIDS-018089; p-Hydroxy-m-methoxy-benzonic acid; 3-Methoxy-4-hydroxybenzoic acid; 4-hydroxy-3-methoxy-benzoic acid; NSC674322; 6746-48-1; 121-34-6; AC1L2LVA; Benzoic acid, 4-hydroxy-3-methoxy-; AI3-19542; SMR000156289; AIDS018089; SBB008280; W398802_ALDRICH; EINECS 204-466-8; 4-hydroxy-3-methoxy benzoic acid; 3-methoxy-4-hydroxybenzoic acid | C8H8O4 | 168.15 g/mol | COC1=C(C=CC(=C1)C(=O)O)O |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
| TCMBANKIN061585 | Ferulaldehyde | AIDS097066; AIDS-097066; ferulaldehyde ; 382051_ALDRICH; 4-Hydroxy-3-methoxycinnamaldehyde; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal; 2-Propenal, 3-(4-hydroxy-3-methoxyphenyl), (E)-; 3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal; 3-(4-hydroxy-3-methoxy-phenyl)acrolein; (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal; InChI=1/C10H10O3/c1-13-10-7-8(3-2-6-11)4-5-9(10)12/h2-7,12H,1H3/b3-2; CHEBI:16547; C02666; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrolein; 458-36-6; Coniferyl aldehyde; ferulaldehyde; 3-(4-hydroxy-3-methoxyphenyl)prop-2-enal; Coniferaldehyde; coniferylaldehyde; coniferaldehyde; trans-coniferyl aldehyde; coniferyl aldehyde; ferulylaldehyde; (E)-ferulaldehyde | C10H10O3 | 178.18 | COC1=C(C=CC(=C1)C=CC=O)O |
| TCMBANKIN061586 | trans-coniferyl alcohol | Coniferyl alcohol;Coniferol;Oprea1_201369; 27740_FLUKA; 2-Propen-1-ol, 3-(4-hydroxy-3-methoxyphenyl), (E)-; 4-[(1E)-3-hydroxy-1-propenyl]-2-methoxyphenol; 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol; 458-35-5; 4-(3-Hydroxy-1-propenyl)-2-methoxyphenol; 2-Propen-1-ol, 3-(4-hydroxy-3-methoxyphenyl)-; ST5330606; ZINC01532694; ZINC01532693; 4-(3-hydroxyprop-1-enyl)-2-methoxyphenol; C00590; CHEBI:17745; 4-[(1E)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenol; 223735_ALDRICH; Coniferyl alcohol; 4-(3-hydroxyprop-1-enyl)-2-methoxy-phenol; 4-Hydroxy-3-methoxycinnamyl alcohol | C10H12O3 | 180.2 g/mol | COC1=C(C=CC(=C1)C=CCO)O |
| TCMBANKIN061628 | Lariciresinol | 27003-73-2; NSC329247; lariciresinol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenol; Lariciresinol, (+)-; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxy-phenyl)methyl]-3-(hydroxymethyl)tetrahydrofuran-2-yl]-2-methoxy-phenol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxy-phenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxy-phenol; 4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)-2-tetrahydrofuranyl]-2-methoxyphenol; 4-[(2S,3R,4R)-4-(4-hydroxy-3-methoxy-benzyl)-3-methylol-tetrahydrofuran-2-yl]-2-methoxy-phenol; C10646; Arbo 4; (+)-lariciresinol | C20H24O6 | 360.4 g/mol | COC1=C(C=CC(=C1)CC2COC(C2CO)C3=CC(=C(C=C3)O)OC)O |
| TCMBANKIN061728 | genkwanin | AIDS003028; ZINC5732375; 4',5-Dihydroxy-7-methoxyflavone; 5-Hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one; 5,4'-Dihydroxy-7-methoxyflavone; 5K3I5D6B2B; Genkwanin, >=98% (HPLC); KBioSS_000810; KBio2_003378; Henquanin; KBioGR_002193; ZINC00058122; Spectrum4_001667; Puddumetin; W1623; 4,5-Dihydroxy-7-methoxyflavone; NCGC00178332-01; DTXSID80195908; TC-169190; KBio2_005946; I07-0230; AKOS015896775; C10046; 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; N2092; 4CN-1073; 437-64-9; C-57765; 4'',5-dihydroxy-7-methoxyflavone; 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromone; KBio2_000810; UNII-5K3I5D6B2B; BDBM50187658; 5-Hydroxy-2-(4-hydroxy-phenyl)-7-methoxy-chromen-4-one; 7-Methylapigenin; 4H-1-Benzopyran-4-one,5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-; SCHEMBL866123; Spectrum2_001355; Genkwanin; Gengkwanin; AIDS-003028; Spectrum_000330; 4'',5-dihydroxy-7-methoxy flavone; MolPort-003-665-822; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-; SPBio_001569; 7'O-methyl-apigenin; 7-Methoxyapigenin; 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-chromenone; MFCD00017452; JPMYFOBNRRGFNO-UHFFFAOYSA-N; ST057642; Gonkwanin; CCG-38838; BRD-K29160894-001-02-9; MCULE-4718928065; Apigenin 7-O-Methyl Ether; BSPBio_003042; Apigenin-7-methylether; KBio3_002262; KBio1_001875; 5-Hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one #; DivK1c_006931; 7-O-Methylapigenin; Spectrum3_001401; FT-0617186; AC1NQYQP; Apigenin 7-methyl ether; LMPK12111018; Spectrum5_000573; CHEBI:75718; 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one; SpecPlus_000835; 4',5-dihydroxy-7-methoxy flavone; ACMC-20amrz; DB-051163; 4',5-Dihydroxy-7-methoxyflavone, AldrichCPR; Flavone, 4',5-dihydroxy-7-methoxy-; Genkwanin, analytical standard; CHEMBL210635; apigenin-7-methyl ether; CTK4I7720; 5,4′-dihydroxy-7-methoxyflavone; | C16H12O5 | 284.26 g/mol | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O |
| TCMBANKIN061736 | sakuranetin | 4',5-Dihydroxy-7-methoxyflavanone; AC1LGHGY; SCHEMBL14410473; ZINC338283; ZB010901; AJ-19902; (2R)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one | C16H14O5 | 286.28 g/mol | COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC=C(C=C3)O)O |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061762 | syringaresinol | (+)-Suyringaresinol-di-O-beta-D-glucoside_qt; (+)syringaresinol; (+)-Suyringaresinol-di-O-beta-D-glucoside; liriodendrin_qt; dl-Syringaresinol; syringaresinol diglucoside_qt; dl-sy-ringaresinol; (+)-syringaresinol-O-β-D-glucopyranoside; (+ )-syringaresinol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 21453-69-0; C10889; (7alpha,7'alpha,8alpha,8'alpha)-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane-4,4'-diol; CHEBI:47; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (+)-syringaresinol; (+ )- syringaresinol; dl-syringaresinol; (-)-syringaresinol; episyringaresinol; (+)-syringarosinol; (+ )-Syringaresinol-O-β-D-glucopyranoside; syringaresino; (-)-syringaresinol; (?)-syringaresinol; (+)-Syringaresinol; lirioresinol-A | C34H46O18 | 742.72 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC |
| TCMBANKIN061763 | (±)-Bbuddlenol D | C33H40O13 | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC(CO)C(C5=CC(=C(C(=C5)OC)O)OC)O)OC | ||
| TCMBANKIN061765 | medioresinol | 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol; 4-[(1S,3aR,4S,6aR)-4-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol; (–)-Medioresinol; (+)-medioresinol; (+)-Medioresinol di-O-beta-D-glucopyranoside_qt; 40957-99-1 | C21H24O7 | 388.4 g/mol | COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC |
| TCMBANKIN061790 | Antiarol | 3,4,5-trimethoxy-phenol; 3,4,5-trimethoxyphenol; EINECS 211-387-2; KBio1_001663; Spectrum5_000193; KBio3_002096; C10765; DivK1c_006719; Spectrum3_001208; Spectrum4_001487; Phenol, 3,4,5-trimethoxy-; KBioSS_001005; Spectrum_000525; BSPBio_002596; InChI=1/C9H12O4/c1-11-7-4-6(10)5-8(12-2)9(7)13-3/h4-5,10H,1-3H; SPECTRUM200110; KBio2_006141; AI3-38432; 3,4,5-Trimethoxyphenol; CHEBI:2760; KBio2_003573; NCGC00095916-01; ZINC00405113; ST5407843; KBioGR_002093; 642-71-7; KBio2_001005; SpecPlus_000623 | C9H12O4 | 184.19 g/mol | COC1=CC(=CC(=C1OC)OC)O |
| TCMBANKIN061792 | syringin | C17H24O9; Glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, D; beta-D-Glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl; LS-172368; Ligustrin (VAN); NSC 287441;syringenone;Syrigin;cis-syringin;ligustrin | C17H24O9 | 372.4 g/mol | COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C=CCO |
| TCMBANKIN061812 | ANN | CHEBI:40813; Anisic acid, p-isomer; ANISIC ACID, PARA; 4-10-00-00346 (Beilstein Handbook Reference); EINECS 202-818-5; C02519; 10550_FLUKA; p-Anisic acid; 4-Methoxybenzoic acid; p-Methoxybenzoic acid; ST5213868; 4-Anisic acid; NCIOpen2_004706; W394505_ALDRICH; NSC32742; 84688_FLUKA; AIDS018080; 117390_ALDRICH; Benzoic acid, 4-methoxy-; 100-09-4; InChI=1/C8H8O3/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5H,1H3,(H,9,10; AI3-00893; AE-848/32075009; AIDS-018080; NSC7926; Draconic acid; EINECS 215-618-8; BRN 0508910; 1335-08-6; Kyselina 4-methoxybenzoova [Czech]; NSC 32742; ANISIC ACID;p-anisic acid;anisicacid;4-methoxy benzoic acid;4-anisate; 4-Methoxybenzoate; Methoxybenzoic acid; anisic acid; BDBM23435; 4-methyoxybenzoate ion; A800042; p-methoxybenzoate; 4-Methoxybenzoic acidanion; CHEBI:16639; p-anisate; AC1MX20M; 4-methoxybenzoate, 4; ZB010665; 16285-97-5; CJ-02856; 4-methoxy benzoic acid; p-methoxybenzoic acid | C8H8O3 | 152.15 | COC1=CC=C(C=C1)C(=O)O |
| TCMBANKIN061838 | 5,7,4'-Trimethylapigenin | Spectrum4_001985; 5631-70-9; 5,7,4'-Trimethoxyflavone; 4',5,7-Trimethoxyflavone; 4',5,7-Trimethyl-apigenin; 4H-1-Benzopyran-4-one, 5,7-dimethoxy-2-(4-methoxyphenyl)-; SPBio_000602; 5,7-dimethoxy-2-(4-methoxyphenyl)-4-chromenone; 5,7,4'-trimethoxyflavone; KBioGR_002516; ST5309227; Spectrum5_001684; 5,7-Dimethoxy-2-(4-methoxyphenyl)-4H-1-benzenopyran-4-one; Flavone, 4',5,7-trimethoxy-; 5,7-dimethoxy-2-(4-methoxyphenyl)chromone; Oprea1_073610; Spectrum3_001138; Spectrum2_000471; 4H-1-Benzenopyran-4-one, 5,7-dimethoxy-2-(4-methoxyphenyl)-; 5,7-dimethoxy-2-(4-methoxyphenyl)chromen-4-one; ZINC02566194; BSPBio_002635; KBio3_002135 | C18H16O5 | 312.32 g/mol | COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC)OC |
| TCMBANKIN061853 | 2-[2-(4'-methoxyphenyl) ethyl] chromone | 2-[2-(4'-methoxyphenyl)ethyl] chromone | COC1=CC=C(C=C1)CCC2=CC(=O)C3=CC=CC=C3O2 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab